Cargando…

Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature

BACKGROUND: Synchronous or metachronous multiple primary malignancies (MPMs) are a known phenomenon. These occurrences may be spontaneous or related to environmental risk factors or genetic predisposition. Chronic myelogenous leukemia (CML) and Multiple myeloma (MM) are two uncommon hematologic mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allahyari, Abolghasem, Maharati, Amirhosein, Jafari-Nozad, Amir Masoud, zangooie, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899381/ https://www.ncbi.nlm.nih.gov/pubmed/36739400 http://dx.doi.org/10.1186/s13256-023-03753-z

Ejemplares similares

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib
por: Ali, Naveed, et al.
Publicado: (2016)

Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)

Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018)

A Rare Case of Chronic Myelogenous Leukemia and Plasma Cell Myeloma in the Same Patient
por: Ahn, Sunhyun, et al.
Publicado: (2015)

Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach
por: Keramatinia, Aliasghar, et al.
Publicado: (2017)

Chronic myelogenous leukemia in ulcerative colitis
por: Katsanos, Konstantinos H., et al.
Publicado: (2011)

Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)

Bosutinib in the management of chronic myelogenous leukemia
por: Amsberg, Gunhild Keller-von, et al.
Publicado: (2013)

Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017)

Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression
por: Maharati, Amirhosein, et al.
Publicado: (2023)

PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

Acute Myelogenous Leukemia Mimicking Fulminant Periorbital Cellulitis
por: Bagheri, Abbas, et al.
Publicado: (2013)

Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature
por: Nagamos, Rochelle Nagales, et al.
Publicado: (2016)

Biomarkers for determining the prognosis in chronic myelogenous leukemia
por: Sweet, Kendra, et al.
Publicado: (2013)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
por: Janani, Gopalarethinam, et al.
Publicado: (2023)

Chronic myelogenous leukemia occurring in a chronic lymphocytic leukemia patient
por: Beaud, Jenny, et al.
Publicado: (2018)

Evaluation of cytokine levels as possible predicting elements in patients with chronic lymphocytic leukemia
por: Khodashenas, Maryam, et al.
Publicado: (2022)

MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2022)

Minimally differentiated acute myelogenous leukemia presented with multiple cervical lymphadenopathy.
por: Choi, J. H., et al.
Publicado: (1996)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
por: Lee, Jae Wook, et al.
Publicado: (2011)

Activation of the hedgehog pathway in chronic myelogeneous leukemia patients
por: Long, Bing, et al.
Publicado: (2011)

Unusual T-Lymphoblastic Blast Phase of Chronic Myelogenous Leukemia
por: Xu, Jie, et al.
Publicado: (2014)

The choice of first-line Chronic Myelogenous Leukemia treatment
por: Fava, Carmen, et al.
Publicado: (2015)

Primary hyperparathyroidism in a case of chronic myelogenous leukemia
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
por: Taghehchian, Negin, et al.
Publicado: (2023)

The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia
por: Allahyari, Abolghasem, et al.
Publicado: (2016)

Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer
por: Shigemizu, Daichi, et al.
Publicado: (2012)

Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature
por: Payandeh, Mehrdad, et al.
Publicado: (2015)

Unusual Case of Simultaneous Presentation of Plasma Cell Myeloma, Chronic Myelogenous Leukemia, and a Jak2 Positive Myeloproliferative Disorder
por: Maerki, J., et al.
Publicado: (2014)

Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia
por: Shea, Lauren K., et al.
Publicado: (2017)

Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous Leukemia
por: Kim, Peter S., et al.
Publicado: (2008)

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy
por: Xu, Zhenshu, et al.
Publicado: (2009)

Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation()
por: Tsukamoto, Shokichi, et al.
Publicado: (2013)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
por: Mashhadi, Mohammad Ali, et al.
Publicado: (2014)

Chronic Myelogenous Leukemia Presenting with Facial Nerve Palsy in an Infant
por: KHAJEH, Ali, et al.
Publicado: (2018)

Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
por: Ross, Theodora S, et al.
Publicado: (2014)

Role of Lysophospholipid Metabolism in Chronic Myelogenous Leukemia Stem Cells
por: Naka, Kazuhito
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0qkchph89j5in4u5h85mviq5d8